Asper Biotech is an appreciated scientific partner in national and international research projects due to its innovation-driven approach and long lasting relationships. The company has been a partner in more than 30 FP6 and FP7 project proposals with 15 having been successfully financed thus far. Membership in FP projects among various international SMEs and Universities has been a great chance to maintain good relationships and find new collaborators all over the world.
FP6 and FP7 projects are run through different consortiums in cooperation with a number of universities, institutes, and SMEs. Asper has communications in Europe, as well as in the USA and Russia. Among our consortium partners are well-known universities and research centers such as Columbia University in the US, the Karolinska Institute in Sweden, the European Genetic Foundation, Pomeranian Medical University and the International Hereditary Cancer Center in Poland, German Cancer Research Center in Heidelberg, Radboud University Nijmegen in the Netherlands, The Cyprus Institute of Neurology and Genetics, University College London, Kings College London, etc.
There is a list of FP6 and FP7 projects with Asper Biotech’s contribution:
FP6 projects: SNP2Chip, ArraySBS, HotSolutes, Mutp53, MedGenet, AO-DNA, Health-e-Child, MolDiagPaca.